Indaptus Therapeutics, Inc. — Form 8-K
Filed October 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Indaptus Therapeutics filed a Form 8-K on October 20, 2026, reporting an event on October 16, 2026. The filing contains only Item 8.01 (Other Events) with no substantive disclosure of facts, dollar amounts, counterparties, or business developments in the accessible text. The actual event details are not provided in this filing summary.
Why this rating
No material event disclosed in accessible text; Item 8.01 only; company scale $5.8M; requires actual document review to assess impact.
Extracted items
See more from October 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.